Assistant Professor, Medicine, UCLA School of Medicine
Infectious Disease
Dr. Aric L. Gregson, MD
|
|
Give Review
Aric Gregson practices Infectious Disease. He studied medicine at David Geffen School of Medicine at UCLA. David Geffen School of Medicine at UCLA is one of the top medical schools in the US. David Geffen School of Medicine at UCLA is ranked 13/7 in Research/PrimaryCare. Aric Gregson is a published MD. He published 27 publications, including: 'The Role of TGF- in the Association Between Primary Graft Dysfunction and Bronchiolitis Obliterans Syndrome.' He is registered with Medicare and accepts Medicare payments.
Publications
- Staphylococcus via an Interaction With the ELR+ CXC Chemokine ENA-78 Is Associated With BOS.
- Survey of preoperative infection prevention for coronary artery bypass graft procedures.
- Variation in Antibiotic Prophylaxis Selection for Coronary Artery Bypass Graft Procedures in an Era of Increasing Methicillin-Resistant Staphylococcus aureus Prevalence.
- Adjunctive Glucocorticoid Therapy for Non-HIV-Related Pneumocystis carinii Pneumonia (NH-PCP).
- CXCR3 Ligands Are Associated with the Continuum of Diffuse Alveolar Damage to Chronic Lung Allograft Dysfunction.
- Colonization with small conidia Aspergillus species is associated with bronchiolitis obliterans syndrome: a two-center validation study.
- Interaction Between Pseudomonas and CXC Chemokines Increases Risk of BOS and Death in Lung Transplantation.
- Usefulness of immune monitoring in lung transplantation using adenosine triphosphate production in activated lymphocytes.
- Respiratory viral infections in hematopoietic stem cell and solid organ transplant recipients.
- Protection against bronchiolitis obliterans syndrome is associated with allograft CCR7+ CD45RA- T regulatory cells.
- Use of hearts transplanted from donors with severe sepsis and infectious deaths.
- Quantification of cytokeratin 5 mRNA expression in the circulation of healthy human subjects and after lung transplantation.
- Bronchoalveolar immunologic profile of acute human lung transplant allograft rejection.
- Phase I trial of an alhydrogel adjuvanted hepatitis B core virus-like particle containing epitopes of Plasmodium falciparum circumsporozoite protein.
- Does antigenic overload exist? The role of multiple immunizations in infants.
- Low infectivity of Plasmodium falciparum gametocytes to Anopheles gambiae following treatment with sulfadoxine-pyrimethamine in Mali.
- Systemic sclerosis and bilateral lung transplantation: a single centre experience.
- Safety and immunogenicity of an AMA-1 malaria vaccine in Malian adults: results of a phase 1 randomized controlled trial.
- Pulmonary hypertension associated with lung transplantation obliterative bronchiolitis and vascular remodeling of the allograft.
- Dengue virus infection.
- Periostitis secondary to prolonged voriconazole therapy in lung transplant recipients.
- Non-tuberculous mycobacterium infection after lung transplantation is associated with increased mortality.
- Implementation of an emergency department triage procedure for the detection and isolation of patients with active pulmonary tuberculosis.
- Altered levels of CC chemokines during pulmonary CMV predict BOS and mortality post-lung transplantation.
- Aspergillus colonization of the lung allograft is a risk factor for bronchiolitis obliterans syndrome.
- The Role of TGF-β in the Association Between Primary Graft Dysfunction and Bronchiolitis Obliterans Syndrome.
Schools
David Geffen School Of Medicine At UCLA University Of California Los Angeles
Harbor Ucla Mc
Center For Vaccine Development University Med Baltimore
University Med
Doctors Specialties
- Infectious Disease Medicine
- Infectious Disease
Accepted Insurances
- Aetna HMO
- Choice Plus POS II
- Blue Card PPO
- Blue Cross Blue Shield of California PPO
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- Open Access Plus
- Commercial Insurance Company
- Blue & Gold HMO
- Covered California - Bronze PPO
- Employer Group HMO
- Health Net PPO
- Individual and Family PPO
- Medicare MCR
- Kaiser PHCS Network PPO
- MultiPlan PPO
- Heritage Signature
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
- PacifiCare HMO
- United Healthcare
Education
-
University of Maryland -
Harbor - UCLA Medical Center -
David Geffen School of Medicine at UCLA
Hospital
-
Ronald Reagan UCLA Medical Center -
Santa Monica-UCLA Medical Center and Orthopaedic Hospital
Drug Facts
| NPI NUMBER | 1588683007 | |
| NPPES Provider LastName | GREGSON | |
| NPPES Provider FirstName | ARIC | |
| NPPES Provider ZIPCode | 90095 | |
| NPPES Provider State | CA | |
| Specialty Description | Infectious Disease | |
| Total Claim Count | 56.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1588683007 |
| Last Name Of The Provider | GREGSON |
| First Name Of The Provider | ARIC |
| View All |
Similar Doctors
|
|
Dr. Shobita Rajagopalan, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Peter Sim, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jason B. Kirk, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Irving Posalski, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Marc J. Lariviere, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Minghsun Liu, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Prashanti Y. Alekal, MD |
|
|
Dr. David O. Beenhouwer, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Paul Holtom, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Jens J. Kort, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Britta Lassmann, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Yoko Miyasaki, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Matthew B. Goetz, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Claire B. Panosian, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Cyril R. Gaultier, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Rachel S. Zabner, MD
This Doctor is OpenDoctor Recommended.
|